Modeling the effectiveness of olfactory testing to limit SARS-CoV-2 transmission
Journal Article
Overview
publication date
- June 16, 2021
has subject area
- Communicable Disease Control
- Coronavirus Infections - COVID-19
- Cost-Benefit Analysis
- Diagnostic Services - Mass Screening
- Diagnostic Techniques and Procedures - COVID-19 Nucleic Acid Testing
- Diagnostic Techniques and Procedures - Mass Screening
- Diagnostic Techniques and Procedures - Viral Load
- Environment and Public Health - Mass Screening
- Environment and Public Health - Prevalence
- Epidemiologic Measurements - Prevalence
- Health Care Evaluation Mechanisms - Mass Screening
- Humans
- Infections - COVID-19
- Infections - COVID-19
- Investigative Techniques - COVID-19 Nucleic Acid Testing
- Investigative Techniques - Mass Screening
- Investigative Techniques - Prevalence
- Investigative Techniques - Viral Load
- Lung Diseases - COVID-19
- Models, Theoretical
- Nervous System Diseases - Anosmia
- Population Characteristics - Prevalence
- Public Health Practice - Mass Screening
- Respiratory Tract Diseases - COVID-19
- Respiratory Tract Diseases - COVID-19
- Signs and Symptoms - Anosmia
- Time Factors
- Virus Diseases - COVID-19
- Virus Physiological Phenomena - Viral Load
has restriction
- gold
Date in CU Experts
- June 22, 2021 6:55 AM
Full Author List
- Larremore DB; Toomre D; Parker R
author count
- 3
citation count
- 10
published in
Other Profiles
Electronic International Standard Serial Number (EISSN)
- 2041-1723
Digital Object Identifier (DOI)
Additional Document Info
volume
- 12
issue
- 1
number
- ARTN 3664